• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • Devex Impact
    • #innov8aid

    Can a new management tool help businesses align to SDGs?

    Novozymes, a global biotech company, is designing a assessment and management tool as part of an effort to align business priorities with the sustainable development goals. The tool, which the company plans to share, helps track impacts and identify business opportunities aligned with solving the global challenges laid out in the SDGs.

    By Adva Saldinger // 02 July 2015
    The sustainable development goals may not be final yet, but one company is already building a new tool that will help guide management decisions to identify business opportunities that align with the new global development framework. Novozymes, a global biotech company, set out a new corporate strategy at the start of the year, one which included sustainability targets of reaching 6 billion people with their technology by 2020, increasing partnerships, reducing carbon dioxide emissions, educating 1 million people and delivering transformative innovation. That strategy led to the company deciding to design a new assessment and management tool to “understand and verify contributions to the SDG context and optimize and maximize contributions going forward,” said Claus Pedersen, Novozyme’s head of corporate sustainability. Novozymes is developing the product as it goes and has tested it in specific cases but continues to refine it as it identifies weaknesses and awaits the finalization of the SDGs. While it isn’t perhaps a perfect tool, or entirely scientific, Pedersen said he believes it can help the company make informed decisions in a better way than in the past. “By understanding the societal contributions of our technologies we get a new language and we can make ourselves much more relevant in the development context,” he said. The tool will build on metrics used in life cycle assessments and add a socio-economic dimension. Different industries feed into different targets so it can relatively quickly determine how to quantify contributions — in some cases only qualitative assessments will be possible and for other sustainable development goals, a business may only be able to verify that it does no harm. The tool will primarily be used to assess the company’s innovation pipeline during the phase where the business case is developed for a particular technology or product. The decision on whether to move a project forward or stop it in its tracks will evaluate the hard business factors with an evaluation of societal impact. Novozymes isn’t interested in keeping the tool a secret. The company is working with the U.N. Global Compact to develop the SDG Compass, a guide for businesses on how to align and integrate sustainability practices with SDGs, which is slated to be launched in September when the SDGs are adopted. It is also sharing and learning from other companies and business organizations as it goes. The broader conversation around private sector participation in the SDGs needs to be reframed according to Pedersen. “Stop talking about rewarding and reputation and accountability; talk about opportunities,” he said. Perhaps new tools, like the one Novozymes is developing, will contribute to changing the conversation and help companies build out a business case for tackling the SDGs. And they may not be alone: Other organizations, like FSG, are also looking at how to turn the goals from problems to business opportunities. You can help shape our coverage on global development innovations by emailing gdb@devex.com or tweeting #innov8aid.

    Related Stories

    Agents of change: Reskilling for AI futures
    Agents of change: Reskilling for AI futures
    Missing at Devex Impact House: How profit can be purpose’s best ally
    Missing at Devex Impact House: How profit can be purpose’s best ally
    Why the World Bank meetings need to have health taxonomy on the agenda
    Why the World Bank meetings need to have health taxonomy on the agenda
    New index aims to help countries close breast cancer care gaps
    New index aims to help countries close breast cancer care gaps

    The sustainable development goals may not be final yet, but one company is already building a new tool that will help guide management decisions to identify business opportunities that align with the new global development framework.

    Novozymes, a global biotech company, set out a new corporate strategy at the start of the year, one which included sustainability targets of reaching 6 billion people with their technology by 2020, increasing partnerships, reducing carbon dioxide emissions, educating 1 million people and delivering transformative innovation.

    That strategy led to the company deciding to design a new assessment and management tool to “understand and verify contributions to the SDG context and optimize and maximize contributions going forward,” said Claus Pedersen, Novozyme’s head of corporate sustainability.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Innovation & ICT
    • Private Sector
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Adva Saldinger

      Adva Saldinger@AdvaSal

      Adva Saldinger is a Senior Reporter at Devex where she covers development finance, as well as U.S. foreign aid policy. Adva explores the role the private sector and private capital play in development and authors the weekly Devex Invested newsletter bringing the latest news on the role of business and finance in addressing global challenges. A journalist with more than 10 years of experience, she has worked at several newspapers in the U.S. and lived in both Ghana and South Africa.

    Search for articles

    Related Stories

    Sponsored by SalesforceRelated Stories - Agents of change: Reskilling for AI futures

    Agents of change: Reskilling for AI futures

    Opinion: NGOsRelated Stories - Missing at Devex Impact House: How profit can be purpose’s best ally

    Missing at Devex Impact House: How profit can be purpose’s best ally

    Opinion: FinanceRelated Stories - Why the World Bank meetings need to have health taxonomy on the agenda

    Why the World Bank meetings need to have health taxonomy on the agenda

    Global healthRelated Stories - New index aims to help countries close breast cancer care gaps

    New index aims to help countries close breast cancer care gaps

    Most Read

    • 1
      Why NTDs are a prime investment for philanthropy
    • 2
      The silent, growing CKD epidemic signals action is needed today
    • 3
      Trump withdraws, defunds dozens of international orgs and treaties
    • 4
      Why are 3.4 billion people still offline?
    • 5
      US lawmakers strike $50B foreign assistance deal, surpassing Trump's plan
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2026 Devex|User Agreement|Privacy Statement